12/19
05:37 pm
mgrx
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent [Yahoo! Finance]
High
Report
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent [Yahoo! Finance]
12/19
05:33 pm
mgrx
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent
High
Report
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent
12/4
07:00 am
mgrx
Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split
Low
Report
Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split
10/31
08:00 am
mgrx
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
Medium
Report
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
10/22
08:00 am
mgrx
MangoRx Announces Formation of Strategy and Alternatives Committee
Low
Report
MangoRx Announces Formation of Strategy and Alternatives Committee
10/21
05:10 pm
mgrx
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly
Medium
Report
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly
10/11
05:15 pm
mgrx
MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN
High
Report
MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN
10/3
08:30 am
mgrx
MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions
High
Report
MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions
10/1
07:30 am
mgrx
MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment
Medium
Report
MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment